Acquisition spree moves Allergan towards innovative drugs
By 
Katrina Krämer2016-09-26T15:06:00
Company acquires five companies in six weeks across three disease areas
By Katrina Krämer2016-09-26T15:06:00
Company acquires five companies in six weeks across three disease areas